UAB "GL Pharma Vilnius" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,004,910 |
167,485 |
48,053 |
38,756 |
6,459 |
100.00 |
3.86 |
228,021 |
57,406 |
4,875 |
279,769 |
2023 |
---|
1,101,340 |
183,557 |
16,822 |
10,947 |
1,825 |
100.00 |
0.99 |
238,968 |
84,054 |
5,341 |
325,685 |
2024 |
---|
1,483,931 |
251,088 |
108,511 |
89,761 |
15,188 |
36.24 |
6.05 |
328,729 |
110,892 |
3,109 |
431,889 |
Register and
explore Okredo data2024 |
---|
1,483,931 |
251,088 |
108,511 |
89,761 |
15,188 |
36.24 |
6.05 |
328,729 |
110,892 |
3,109 |
431,889 |
Register and
explore Okredo data2024
Turnover (€)
1,483,931 €35 % *
Sales per employee (€)
251,088 €37 % *
Profit before tax (€)
108,511 €545 % *
Net Profit (€)
89,761 €720 % *
Profit per employee (€)
15,188 €732 % *
Total profitability (%)
36.24 %-63.76 % *
Net profitability (%)
6.05 %511.11 % *
Equity (€)
328,729 €38 % *
Amounts Payable And Liabilities (€)
110,892 €32 % *
Non-current Assets (€)
3,109 €-42 % *
CurrentAssets (€)
431,889 €33 % *